Nicotine Pouches and Sleep: What the Research Actually Shows

Pouches arrive with a reputation for being the tidy option: no smoke, no vapor, no smell. That reputation is about the lungs and the room. Your sleep is run by a nervous system that does not care how the nicotine got there. Here is what the research can and cannot say about it.

1. How a pouch gets nicotine into your blood

A pouch sits between lip and gum. Nicotine moves through the lining of the mouth, not the stomach, and enters circulation without passing through the gut first. In a randomized seven-way crossover study of regular pouch users, peak plasma nicotine rose with pouch strength and with how long the pouch stayed in: roughly 19 to 22 ng/mL for 11 mg pouches and 27 to 34 ng/mL for 20 mg pouches, depending on use time. Very little nicotine was swallowed, only about 1.8 percent of the pouch content showed up in saliva.

Citation: Azzopardi D, Brown E, Meichanetzidis F, et al. A randomized crossover clinical study to assess the effect of oral nicotine pouches used for different durations on plasma nicotine pharmacokinetics in healthy oral pouch consumers. J Clin Pharmacol, 2026. PubMed: 40781988

One caveat that matters: the authors were employees of a tobacco company, which also funded the study. The pharmacokinetic measurements are routine and hard to fudge, but we note the source.

2. The half-life problem

Nicotine leaves plasma with an average half-life of about 2 hours. Its main metabolite, cotinine, averages about 16 hours. A longer terminal phase, around 11 hours, shows up when urinary excretion is tracked, because low concentrations clear more slowly. Our own arithmetic, assuming a clean 2-hour half-life and ignoring that longer tail: a pouch that peaks at 9 pm leaves about a quarter of that peak in your blood at 1 am. In daily users who stack pouches through the evening, the real number is higher.

Citation: Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol, 2009. PubMed: 19184645

3. What nicotine does to sleep when it is on board overnight

The cleanest evidence comes from giving non-smokers nicotine by patch and recording the night. In 66 healthy non-smokers aged 20 to 25, a 16 mg patch worn overnight shortened sleep period time, lowered sleep efficiency, increased time awake and shortened REM latency, and volunteers rated their sleep as worse. The changes showed up with the 16 mg patch, and the authors describe the effect as dose-dependent. Arousals, apneas and leg movements were not affected.

Citation: Jaehne A, Unbehaun T, Feige B, et al. The influence of 8 and 16 mg nicotine patches on sleep in healthy non-smokers. Pharmacopsychiatry, 2014. PubMed: 24687640

A crossover polysomnography study of 16 young non-smoking men found the same direction: longer sleep latency, more wake after sleep onset, more light stage 1 sleep, less total sleep time, lower sleep efficiency and a lower share of REM. Slow wave activity was reduced in stage 2 and REM sleep, and the authors tied the changes to sympathetic overactivation.

Citation: Choi JB, Lee YG, Jeong DU. Transdermal nicotine patch effects on EEG power spectra and heart rate variability during sleep of healthy male adults. Psychiatry Investig, 2017. PubMed: 28845178

An older Mayo Clinic trial used an 11 mg patch worn from 6 pm to 6 am by 20 non-smoking habitual snorers. Nicotine cut total sleep time by 33 minutes, dropped sleep efficiency from 89.7 to 83.5 percent, reduced REM from 18.8 to 15.1 percent and stretched sleep latency from 6.7 to 18.2 minutes.

Citation: Davila DG, Hurt RD, Offord KP, Harris CD, Shepard JW Jr. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med, 1994. PubMed: 8049831

Limits worth stating. All three are small. Patches release nicotine steadily for the whole night, while a pouch is a burst that decays, so the overnight exposure from an evening pouch is probably lower and shaped differently. And the volunteers were non-smokers with no built-up tolerance, so daily users may respond differently.

4. What daily nicotine users look like on a sleep study

A 2026 cross-sectional study recorded overnight polysomnography in 160 people: active smokers, former smokers, never-smokers and nicotine replacement users who were past the acute withdrawal window. Deep sleep (N3) was shorter in replacement users, by about 32 minutes against never-smokers (p < .001), and by about 28 minutes against former smokers (p = .004). Active smokers were about 20 minutes short, but that gap did not reach significance (p = .32). Former smokers did not show the reduction, which hints the loss reverses. Replacement users also had more micro-arousals and more sleep complaints.

Citation: Mallevays M, Mauries S, Maruani J, et al. Effects of nicotine on sleep architecture and ventilatory parameters: results of the Tab-OSA cross-sectional observational study. Sleep Med, 2026. PubMed: 41197178

This is observational, so it cannot prove nicotine caused the difference, and nobody in it was a pouch user. What it adds is that deep sleep loss showed up in people getting nicotine without smoke, which points at the nicotine.

5. The 3 am question: withdrawal during the night

Daily users carry a second problem. If you are dependent, nicotine falling across the night may nudge you toward lighter sleep, which the authors above proposed to explain the micro-arousals in replacement users. A systematic review of sleep after quitting found that sleep alterations tend to persist through the first weeks of withdrawal and predict relapse, although results are heterogeneous and the evidence that sleep restores afterward, including with replacement therapy, is limited.

Citation: Mauries S, Rolland B, Mallevays M, et al. Conditions of sleep restoration after smoking cessation: a systematic review. Sleep Med Rev, 2025. PubMed: 39893864

To be fair to the other side: the patch study above found no evidence of withdrawal-related sleep changes after 13 hours in non-smokers. They were not dependent, so the finding does not cancel the dependent-user hypothesis. It does mean the withdrawal story is a hypothesis, not a result.

6. The younger-user angle, and what we are extrapolating

The closest data on the population most likely to use pouches comes from vaping. A 2026 structured narrative review of six empirical studies found that exclusive e-cigarette use was consistently linked to 30 to 80 percent higher odds of insufficient sleep among adolescents and young adults, and dual users of cigarettes and e-cigarettes were up to three times more likely to report inadequate sleep. The authors flag that the relationship may run both ways: poor sleep may also raise the chance of starting.

Citation: Mishra N, Mehta R. The association between e-cigarette use and sleep duration among adolescents and young adults: a structured narrative review. Cureus, 2026. PubMed: 42598725

Vapes are not pouches. We are using them because they share the nicotine and the age group, and we are saying so. This is also a review of mostly self-reported, observational studies, so it supports concern and not a conclusion.

What the evidence supports, graded

Nicotine in your system overnight disrupts sleep in controlled trials: consistent direction, small studies. Daily users have less deep sleep: moderate, observational. Overnight withdrawal drives awakenings: plausible, unproven. Pouches specifically: no sleep study that we could find.

Where Lunia fits

If nicotine is part of your evening, the most useful lever in the research is the one outside any bottle: how much nicotine is in your system at bedtime. Lunia Restore is a melatonin-free capsule with 90 mg of elemental magnesium (from 500 mg of magnesium bisglycinate), 300 mg of L-theanine and 50 mg of apigenin, every amount printed on the label. It is not a nicotine product, it was not tested in nicotine users, and no supplement offsets what nicotine does to sleep. There is no randomized trial on the finished formula, and our evidence is at the ingredient level.

Learn more about Lunia Restore

Frequently Asked Questions

Do nicotine pouches affect sleep?

The direct evidence is thin. No one has run overnight sleep recordings on regular pouch users that we could find. What exists is trials giving nicotine to non-smokers overnight by patch, which lengthened the time to fall asleep and cut sleep efficiency, plus observational data on people who use nicotine every day. Pouches deliver the same molecule, so the findings are relevant, but they are not a direct test.

How long before bed is too late for a nicotine pouch?

No study has set a cutoff. Nicotine's plasma half-life averages about 2 hours, and its main metabolite lingers for roughly 16, so an evening pouch leaves nicotine in circulation at bedtime. If you want a personal cutoff or help cutting back, a clinician can tailor it to you.

Do nicotine pouches reduce REM sleep?

In the patch trials, REM percentage fell in two of them (about 18.8 to 15.1 percent in one, and a significant drop in another), while REM latency shortened in a third. The results are not perfectly consistent, they come from small samples, and patches deliver nicotine continuously all night, which a pouch does not.

Could nicotine withdrawal be waking me up at night?

It is plausible and unproven. Researchers studying daily nicotine users have suggested that falling nicotine levels overnight could drive micro-awakenings, and withdrawal-related sleep changes can persist for the first few weeks after quitting. A 2014 study in non-smokers saw no withdrawal effect after 13 hours, but those volunteers were not dependent.

Are pouches better for sleep than cigarettes?

No head-to-head sleep trial exists. One 2026 study found shorter deep sleep in both active smokers and nicotine replacement users compared with never-smokers, which points at nicotine rather than smoke, but it was a single cross-sectional comparison and cannot prove cause.

Does Lunia Restore help with sleep disrupted by nicotine?

We have no data on that. There is no randomized trial of Restore in nicotine users, and no randomized trial on the finished formula at all. Our evidence is at the ingredient level. If nicotine is part of your evening, talk to a clinician about the best route to cutting back.

The Bottom Line

Pouches change the delivery, not the molecule. Nicotine is a stimulant with a half-life long enough to still be around at bedtime, and the controlled trials we have show it costing sleep in the ways you would predict. The pouch-specific sleep studies have not been done, so anyone telling you pouches are fine for sleep, or ruinous for it, is ahead of the data. If you use them in the evening and your sleep is off, the timing of your last pouch is the first variable worth looking at, ideally with a clinician.

References

1. Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol, 2009. PubMed: 19184645
2. Azzopardi D, Brown E, Meichanetzidis F, et al. A randomized crossover clinical study to assess the effect of oral nicotine pouches used for different durations on plasma nicotine pharmacokinetics in healthy oral pouch consumers. J Clin Pharmacol, 2026. PubMed: 40781988
3. Jaehne A, Unbehaun T, Feige B, et al. The influence of 8 and 16 mg nicotine patches on sleep in healthy non-smokers. Pharmacopsychiatry, 2014. PubMed: 24687640
4. Choi JB, Lee YG, Jeong DU. Transdermal nicotine patch effects on EEG power spectra and heart rate variability during sleep of healthy male adults. Psychiatry Investig, 2017. PubMed: 28845178
5. Davila DG, Hurt RD, Offord KP, Harris CD, Shepard JW Jr. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med, 1994. PubMed: 8049831
6. Mallevays M, Mauries S, Maruani J, et al. Effects of nicotine on sleep architecture and ventilatory parameters: results of the Tab-OSA cross-sectional observational study. Sleep Med, 2026. PubMed: 41197178
7. Mauries S, Rolland B, Mallevays M, et al. Conditions of sleep restoration after smoking cessation: a systematic review. Sleep Med Rev, 2025. PubMed: 39893864
8. Mishra N, Mehta R. The association between e-cigarette use and sleep duration among adolescents and young adults: a structured narrative review. Cureus, 2026. PubMed: 42598725

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.